Adverse drug events in ambulatory care. - Wikidata - wikimedia - TriplyDB

Adverse drug events in ambulatory care.

Adverse drug events in ambulatory care.

http://www.wikidata.org/entity/Q34191226

about

Providing physicians with feedback on medication adherence. Effect on processes of care and patient outcomes Interventions in primary care for reducing preventable medication errors that lead to hospital admissions, mortality and emergency department visits David Westfall Bates, MD: a conversation with the editor on improving patient safety, quality of care, and outcomes by using information technology. Interview by William Clifford Roberts Personal health records: definitions, benefits, and strategies for overcoming barriers to adoption.Medication-related problem type and appearance rate in ambulatory hemodialysis patients The effect of automated alerts on provider ordering behavior in an outpatient setting Indicators for Evaluating the Performance and Quality of Care of Ambulatory Care Nurses A research agenda on patient safety in primary care. Recommendations by the LINNEAUS collaboration on patient safety in primary care Improving medication safety in primary care. A review and consensus procedure by the LINNEAUS collaboration on patient safety in primary care Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review Continuity of medication management and continuity of care: Conceptual and operational considerations Systolic BP and Mortality in Older Adults with CKD.Histological spectrum of cutaneous reactions to aspirin in chronic idiopathic urticaria Aspirin for everyone older than 50? For Effect of content and format of prescription drug labels on readability, understanding, and medication use: a systematic review Trends in antibiotic prescribing in adults in Dutch general practice Patients' insight of interpreting prescriptions and drug labels--a cross sectional study Prevalence and perceived preventability of self-reported adverse drug events--a population-based survey of 7099 adults Polypharmacy patterns: unravelling systematic associations between prescribed medications Are we heeding the warning signs? Examining providers' overrides of computerized drug-drug interaction alerts in primary care Medication monitoring in a nurse-led respiratory outpatient clinic: pragmatic randomised trial of the West Wales Adverse Drug Reaction Profile Development and validation of a risk model for predicting adverse drug reactions in older people during hospital stay: Brighton Adverse Drug Reactions Risk (BADRI) model Effects of polypharmacy on adverse drug reactions among geriatric outpatients at a tertiary care hospital in Karachi: a prospective cohort study Patterns of Adverse Drug Reactions in Different Age Groups: Analysis of Spontaneous Reports by Community Pharmacists Incidence and Effects of Polypharmacy on Clinical Outcome among Patients Aged 80+: A Five-Year Follow-Up Study Medication incidents in primary care medicine: protocol of a study by the Swiss Federal Sentinel Reporting System Two complementary personal medication management applications developed on a common platform: case report Using electronic health records to help coordinate care Pharmacogenomics of off-target adverse drug reactions.Patient safety in the ambulatory setting. A clinician-based approach.A conceptual framework for evaluating outpatient electronic prescribing systems based on their functional capabilities.Clinical decision support in electronic prescribing: recommendations and an action plan: report of the joint clinical decision support workgroup.The Red flag! risk assessment among medical homeopaths in Norway: a qualitative study.Developing a medication communication framework across continuums of care using the Circle of Care Modeling approach.Multidrug and optimal heart failure therapy prescribing in older general practice populations: a clinical data linkage study.An individual patient data meta-analysis on factors associated with adverse drug events in surgical and non-surgical inpatients Data feedback and behavioural change intervention to improve primary care prescribing safety (EFIPPS): multicentre, three arm, cluster randomised controlled trial.Frequency and clinical relevance of potential cytochrome P450 drug interactions in a psychiatric patient population - an analysis based on German insurance claims data.Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998-2005.Data-driven methods to discover molecular determinants of serious adverse drug events.

P2860

Q24186763-45CA5DD1-9C3D-4902-82DA-B9BA5892AE1A Q24202777-A27BD431-A895-4E47-A4CD-0F59D41D2F6D Q24531987-BB2F3481-215F-4FC3-A19A-145E658779F3 Q24544267-4C2C8072-3787-4E10-BD49-C7ED3C7EF44E Q24805292-9A52C250-6DB5-4251-8DC3-DE27C52F9A98 Q24810442-7D5F90B9-522F-4B29-99F5-3A2B3CC5A544 Q26784166-344BF752-F50E-4B88-A9BA-43F58FB57C8C Q26784320-738CA0D5-6F8E-4A6F-B617-80F8F790D569 Q26784395-C3724540-AE94-4EE2-A02F-CF6246E7A995 Q26821828-2284B27D-1141-40A6-8EFA-6E3AA0948D9D Q26866530-E0D05E76-5282-4BD0-91A3-D067ADC1FC4F Q27335475-B7013DAC-D488-41BF-95E4-D5E228DBC7E0 Q28167614-C73B8415-3A4A-414B-90CD-626374C6A865 Q28180812-C2F0FC5C-96AD-48E4-85DD-23C3A06E6EB5 Q28297440-F7D9E10C-B588-498C-BC8A-D3D0E3E9CF8A Q28484302-D643F862-B46C-4A28-9C65-242B1D84B45B Q28533581-60048EC6-D166-4402-AF1E-AF692C814310 Q28536709-30A299FD-9683-463C-BFAC-30AC0B0105D5 Q28537875-96FB0C3B-B107-4056-9515-765B6252C54F Q28538031-686F0860-4204-4125-A670-4BAB525EAB28 Q28538501-078F1C9E-579C-4173-A47D-56E0A1CF1771 Q28544629-E97B1E85-552F-4FAB-AD26-8E610F4F35F5 Q28544992-54DB7C4B-43BB-4F3E-B5F9-9FC6D3870E5E Q28546491-ADE2CBC7-A419-40EC-8368-5934B527BDE9 Q28550797-1D5EB551-C028-48B2-81A4-0D12021FDB8D Q28648433-E1FCD643-7B45-4A76-8CD2-EC04B45ED4C1 Q28742401-180F7A2C-8EFF-4E3C-B113-84AE25561D15 Q28752635-07E1A2DD-F745-4D2C-BC41-A5BFAEEA4134 Q30400366-C51818C3-5834-4DA8-B5FE-90C10652E79C Q30433770-B6185116-354D-466D-9F1B-DE12CD1D2B47 Q30449486-42C52DAE-A06C-40AD-8FB6-23D1216E5E54 Q30476021-2D8DBBEE-0599-4DCE-9566-21EF3285A206 Q30527903-B5E4AC98-9D64-44F0-8141-24080320E3F4 Q30558788-7D4B5D57-C00E-428B-A29C-BABD93B885B4 Q30725233-68E7A644-5960-4FB1-B5F9-578F5C25332F Q30848287-5EE30E19-B30D-434F-9116-598487125D3E Q31122448-8ABAF9F8-1E31-4C34-A544-8EECCBD6695B Q31127895-E812C58D-1B8B-4B4F-831D-0C50EC527AD1 Q33300293-F2008BDB-7565-487E-BF42-DB4B51FADB44 Q33403734-3C91A0F8-0DB2-424D-B2B7-4CA84EA6B175

P2860

Adverse drug events in ambulatory care.

http://www.wikidata.org/entity/Q34191226

description

2003 nî lūn-bûn

@nan

2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Adverse drug events in ambulatory care.

@ast

Adverse drug events in ambulatory care.

@en

Adverse drug events in ambulatory care.

@nl

type

label

Adverse drug events in ambulatory care.

@ast

Adverse drug events in ambulatory care.

@en

Adverse drug events in ambulatory care.

@nl

prefLabel

Adverse drug events in ambulatory care.

@ast

Adverse drug events in ambulatory care.

@en

Adverse drug events in ambulatory care.

@nl

P1433

Q34191226-A97C4E0F-89DF-4754-8CB5-87E5D2DB7ADA

P1476

Q34191226-C295D226-BD64-4822-9B18-C16B0546C69D

P2093

Q34191226-20368398-63FE-41EF-B1D4-6972274F667C

Q34191226-25A4F812-9561-4FC2-A1A6-39E07EF0052C

Q34191226-2C1CCAC6-D4E3-491F-8774-69312E5033AA

Q34191226-432981CD-739C-44CE-8C8C-3B2B268D7852

Q34191226-612B0DC3-8898-47EE-BFFF-CADE7E0CA8F4

Q34191226-A8C9DE96-779C-493F-B542-96531152E016

Q34191226-B26932AE-A07F-4063-9D13-7B12BA998416

Q34191226-C15BE58F-3C34-484A-B036-419BD6E67C86

Q34191226-C61E2013-8BD5-495B-8BAD-A72AF984E619

Q34191226-DCE6849F-8A99-4F32-94C9-CC04E7E24D79

P304

Q34191226-86912C6C-2235-4C07-8D8B-DFA7A9351DA1

P31

Q34191226-701E9624-A5FA-42A5-828C-69557F6A2635

P356

Q34191226-C6A5B512-2695-461A-A5CD-1F86A7261614

P407

Q34191226-192B7584-19DA-459C-A78F-F2C323E66362

P433

Q34191226-C802F908-7385-4824-9E11-0D36EE64F657

P478

Q34191226-F437DA7C-641D-4C9E-A531-3EDA9367F357

P577

Q34191226-12E560B9-B340-475F-9F46-DED0DAA2BA7F

P698

Q34191226-643F3C56-ACD8-41E0-A849-1CFDD7093469

P356

P1433

The New England Journal of Medicine

P1476

Adverse drug events in ambulatory care.

@en

P2093

Andrew C Seger

http://www.w3.org/2001/XMLSchema#string

David W Bates

http://www.w3.org/2001/XMLSchema#string

Diane L Seger

http://www.w3.org/2001/XMLSchema#string

Elisabeth Burdick

http://www.w3.org/2001/XMLSchema#string

Frank Federico

http://www.w3.org/2001/XMLSchema#string

Josh Peterson

http://www.w3.org/2001/XMLSchema#string

Joshua Borus

http://www.w3.org/2001/XMLSchema#string

Kirstin Shu

http://www.w3.org/2001/XMLSchema#string

Lucian L Leape

http://www.w3.org/2001/XMLSchema#string

Saul N Weingart

http://www.w3.org/2001/XMLSchema#string

P304

1556-1564

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMSA020703

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

348

http://www.w3.org/2001/XMLSchema#string

P577

2003-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12700376

http://www.w3.org/2001/XMLSchema#string